Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3378)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,036
Price
$550.32
Total Value
$1.12M
Shares Held After
43,597
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,113
Price
$549.13
Total Value
$611.18K
Shares Held After
45,633
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,027
Price
$548.42
Total Value
$1.11M
Shares Held After
46,746
% of Holdings
4.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
542
Price
$547.12
Total Value
$296.54K
Shares Held After
48,773
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
525
Price
$546.04
Total Value
$286.67K
Shares Held After
49,315
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
173
Price
$545.18
Total Value
$94.32K
Shares Held After
49,840
% of Holdings
0.3%
Korro Bio, Inc. (KRRO)
Chappell Todd — Chief Operating Officer
Shares
3,168
Price
$10.83
Total Value
$34.31K
Shares Held After
16,964
% of Holdings
15.7%
Tarsus Pharmaceuticals, Inc. (TARS)
Farrow Jeffrey S — Chief Financial Officer and Chief Strategy Officer
Shares
14,396
Price
$60.95
Total Value
$877.44K
Shares Held After
56,801
% of Holdings
20.2%
NeuroSense Therapeutics Ltd. (NRSN)
Ben-Noon Alon — Chief Executive Officer
Shares
250,000
Price
$0.80
Total Value
$200.00K
Shares Held After
4,534,233
% of Holdings
5.5%
NeuroSense Therapeutics Ltd. (NRSN)
Eisenberg Or — Chief Financial Officer
Shares
250,000
Price
$0.80
Total Value
$200.00K
Shares Held After
1,504,050
% of Holdings
16.6%
Dyne Therapeutics, Inc. (DYN)
Kerr Douglas — Chief Medical Officer
Shares
887
Price
$18.33
Total Value
$16.26K
Shares Held After
169,155
% of Holdings
0.5%
Upstream Bio, Inc. (UPB)
Houghton Adam — Chief Business Officer
Shares
700
Price
$6.10
Total Value
$4.27K
Shares Held After
23,601
% of Holdings
2.9%
Upstream Bio, Inc. (UPB)
GRAY MICHAEL — CFO and COO
Shares
853
Price
$6.10
Total Value
$5.20K
Shares Held After
28,795
% of Holdings
2.9%
Upstream Bio, Inc. (UPB)
Sutherland Everett Rand — Director
Shares
2,095
Price
$6.10
Total Value
$12.78K
Shares Held After
70,812
% of Holdings
2.9%
Upstream Bio, Inc. (UPB)
Ambrose Allison — General Counsel
Shares
477
Price
$6.10
Total Value
$2.91K
Shares Held After
16,048
% of Holdings
2.9%
Korro Bio, Inc. (KRRO)
Dolan Oliver — Senior Vice President, Finance
Shares
3,383
Price
$10.83
Total Value
$36.64K
Shares Held After
18,099
% of Holdings
15.7%
Dyne Therapeutics, Inc. (DYN)
Cox John — Director
Shares
2,683
Price
$18.33
Total Value
$49.18K
Shares Held After
368,151
% of Holdings
0.7%
Upstream Bio, Inc. (UPB)
Deykin Aaron — Chief Medical Officer
Shares
895
Price
$6.10
Total Value
$5.46K
Shares Held After
33,197
% of Holdings
2.6%
Korro Bio, Inc. (KRRO)
Cerio Jeffrey — General Counsel
Shares
6,609
Price
$10.83
Total Value
$71.58K
Shares Held After
35,293
% of Holdings
15.8%
Dyne Therapeutics, Inc. (DYN)
Friedl-Naderer Johanna — Chief Commercial Officer
Shares
145
Price
$18.33
Total Value
$2.66K
Shares Held After
154,208
% of Holdings
0.1%
Anixa Biosciences Inc (ANIX)
Titterton Lewis H jr — Director
Shares
2,836
Price
$2.64
Total Value
$7.49K
Shares Held After
972,170
% of Holdings
0.3%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
1,035
Price
$145.02
Total Value
$150.10K
Shares Held After
25,000
% of Holdings
4.0%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
1,897
Price
$143.55
Total Value
$272.31K
Shares Held After
26,035
% of Holdings
6.8%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
450
Price
$142.20
Total Value
$63.99K
Shares Held After
27,932
% of Holdings
1.6%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
100
Price
$141.83
Total Value
$14.18K
Shares Held After
28,382
% of Holdings
0.4%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
540
Price
$140.58
Total Value
$75.91K
Shares Held After
28,482
% of Holdings
1.9%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
3,140
Price
$139.57
Total Value
$438.26K
Shares Held After
29,022
% of Holdings
9.8%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
784
Price
$138.18
Total Value
$108.33K
Shares Held After
32,162
% of Holdings
2.4%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
2,054
Price
$137.61
Total Value
$282.64K
Shares Held After
32,946
% of Holdings
5.9%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
9,939
Price
$0.37
Total Value
$3.68K
Shares Held After
331,414
% of Holdings
2.9%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
139,686
Price
$0.37
Total Value
$51.68K
Shares Held After
4,657,664
% of Holdings
2.9%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
124,893
Price
$8.89
Total Value
$1.11M
Shares Held After
16,763,043
% of Holdings
0.7%
Dermata Therapeutics, Inc. (DRMA)
Scott Kathleen D. — Director
Shares
11
Price
$1.19
Total Value
$13.09
Shares Held After
0
% of Holdings
100.0%
Aura Biosciences, Inc. (AURA)
Gibney Anthony S — Chief Financial and Business Officer.
Shares
12,824
Price
$6.42
Total Value
$82.33K
Shares Held After
265,354
% of Holdings
4.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
9,890
Price
$23.81
Total Value
$235.49K
Shares Held After
57,095
% of Holdings
14.8%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
4,096
Price
$24.41
Total Value
$99.98K
Shares Held After
38,378
% of Holdings
9.6%
Arcutis Biotherapeutics, Inc. (ARQT)
LIN SUE-JEAN — Director
Shares
4,946
Price
$24.38
Total Value
$120.59K
Shares Held After
27,567
% of Holdings
15.2%
Stablecoin Development Corp (SDEV)
Kazley Michael John — Director
Shares
24,720
Price
$1.09
Total Value
$26.94K
Shares Held After
22,668,516
% of Holdings
0.1%
Stablecoin Development Corp (SDEV)
Framework Ventures IV L.P. — 10% Owner
Shares
24,720
Price
$1.09
Total Value
$26.94K
Shares Held After
22,668,516
% of Holdings
0.1%
Stablecoin Development Corp (SDEV)
R01 Fund LP — 10% Owner
Shares
24,720
Price
$1.09
Total Value
$26.94K
Shares Held After
22,668,516
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
100,000
Price
$17.37
Total Value
$1.74M
Shares Held After
1,412,058
% of Holdings
6.6%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
60,400
Price
$160.17
Total Value
$9.67M
Shares Held After
158,222
% of Holdings
27.6%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
6,657
Price
$16.39
Total Value
$109.08K
Shares Held After
232,457
% of Holdings
2.8%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
3,328
Price
$16.38
Total Value
$54.53K
Shares Held After
239,114
% of Holdings
1.4%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
3,329
Price
$16.39
Total Value
$54.56K
Shares Held After
242,442
% of Holdings
1.4%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
272,322
Price
$45.02
Total Value
$12.26M
Shares Held After
7,388,902
% of Holdings
3.6%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
9,086
Price
$45.02
Total Value
$409.05K
Shares Held After
245,728
% of Holdings
3.6%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
5,538
Price
$60.71
Total Value
$336.21K
Shares Held After
15,437
% of Holdings
26.4%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
96,000
Price
$0.04
Total Value
$4.32K
Shares Held After
93,389,560
% of Holdings
0.1%
CytomX Therapeutics, Inc. (CTMX)
Ogden Christopher — Chief Financial Officer
Shares
1,624
Price
$3.05
Total Value
$4.95K
Shares Held After
295,324
% of Holdings
0.5%
Showing 1701–1750 of 3378 transactions (page 35 of 68)